| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |